Tuesday 11 May 2021

Medical Cannabis as a Pharmaceutical: Microbiological Risk and Quality Control


There is a continuing interest in the established and potential therapeutic properties of medical cannabis. These properties are due to cannabinoids, which are a group of compounds present in cannabis. As this interest continues in medicinal cannabis, the quality of medicinal cannabis needs to be strengthened. This means applying a robust microbiological standard. This also means the same standards applied as they would to any other pharmaceutical preparation.


This article considers the microbiological aspects; a previous article looked at the analytical methods and outcomes in relation to medicinal cannabis manufacturing (and the first article in this series considered medical and pharmaceutical cannabis products in general). 



The reference is:


Sandle, T. (2021): Medical Cannabis as a Pharmaceutical – Part 3: Microbiological Risk and Quality Control, Journal of GxP Compliance, 25 (1): https://www.ivtnetwork.com/article/medical-cannabis-pharmaceutical-%E2%80%93-part-3-microbiological-risk-and-quality-control

 Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers